. An A-to-G nucleotide transition at position 985 of the MCAD gene was found to be the most common mutation, accounting for -89% of the mutant alleles purified polymerase chain reaction (PCR) product or allele-specific oligonucleotide hybridization as the method for the laboratory diagnosis of this mutation (1, (4) (5) (6) . A simple method known as the amplification refractory mutation system (ARMS) has been used in the genotyping of apolipoprotein E alleles (7) and known mutations of several disorders (8, 9). Here we used ARMS to provide a rapid and reliable method for diagnosing the 985 A-to-G mutation in MCAD deficiency.
between subsequent episodes. The disorder has been associated with sudden infant death syndrome and has a Reye-like clinical presentation (1-4). An A-to-G nucleotide transition at position 985 of the MCAD gene was found to be the most common mutation, accounting for -89% of the mutant alleles 3Nonstandard abbreviations: MCAD, medium-chain acyl-coA dehydrogenase; PCR, polymerase chain reaction; and ARMS, amplification refractory mutation system.
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purified polymerase chain reaction (PCR) product or allele-specific oligonucleotide hybridization as the method for the laboratory diagnosis of this mutation (1, [4] [5] [6] . A simple method known as the amplification refractory mutation system (ARMS) has been used in the genotyping of apolipoprotein E alleles (7) and known mutations of several disorders (8, 9). Here we used ARMS to provide a rapid and reliable method for diagnosing the 985 A-to-G mutation in MCAD deficiency.
Materials and
Methods DNA was isolated from peripheral blood by the method of Miller et al. (10) . Oligonucleotide primers used for PCR amplification that introduce an Nco I restriction site in the mutant allele (1) have the following sequences: 5'ATATCA'lTFATGCTGGCTGAAA-TGGCCATG3' (sense) and 5'ACCAGAATCAACCTC-CCAAG3' (antisense). For ARMS reaction, the sequence of the allele-specific sense primer for the wild type was 5'ATGCTGGCTGAAATGGCAATFA3', and the sequence of the allele-specific sense primer for the 985 mutant was 5'ATGCTGGCTGAAATGGCAAI'TG3'.
To ensure allele specificity, the penultimate base at the 3' end of both primers was deliberately altered to substitate a T for G (7, 8) . The common (antisense) primer was the same as that used for the Nco I digestion method.
PCR followed by Nco I digestion was done as described by Yokota et al. For the ARMS reaction, two PCR reactions were performed for each sample: the sense primer specificfor the wild-type allele was used in one and the sense primer for the mutant allele was used in the other. The common antisense primer was added to both reactions. In addition, primers for exon 2 of the ornithune transcarbamylase gene were added as a control to produce a 162-bp fragment. All reactions were carried out with 1 g of genomic DNA and 2.5 U of Amplitaq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT) in a total volume of 100 L, containing 10 mmol/L Tris (pH 8.3), 1.5 mmol/L MgCl2, 50 mmolIL KC1, 0.02 mol of each of the four deoxynucleoside triphosphates, and 20 pmol of each of the ARMS and internal-control primers. The reaction mix was overlaid with mineral oil. The amplification cycles were as follows: denaturation at 95#{176}C for 5 miii, primer annealing at 55#{176}C for 2 mm, and primer extension at 72 #{176}C for 2 mm. This was followed by 30 cycles of denaturation at 95 #{176}C for 1 mi primer annealing at 55#{176}C for 2 mm, and primer extension at 72#{176}C for 2 mm. Finally, there was one cycle of denaturation at 95 #{176}C for 1 mm, primer annealing at 55 #{176}C for 2 miii, and primer extension at 72#{176}C for 7 mm. Reactions were carried out with an Ericomp (San Diego, CA) twin-block thermal cycler. PCR products were electrophoresed on a 4% agarose gel containing ethidium bromide.
Urine organic acid analyses were performed as previously described (11).
Two families were studied. The subject in family A was 42 months old when he presented with lethargy, diarrhea, dehydration, and hepatomegaly. He was found to have hypoketogenic hypoglycemia (1.9 mmolIL), a highly increased leukocyte count (52 000/mm3), metabolic acidosis (serum CO2 10 mmoIIL), mild liver dysfunction, and highly increased serum uric acid (2.1 mnnol/L). Urinary organic acid analysis revealed dicarboxylic aciduria (high concentrations of adipic, suberic, and sebacic acids) and high concentrations of hexanoylglycine, suberylglycine, phenylpropionylglycine, 5-hydroxyhexanoic acid, and 7-hydroxyoctanoic acid. Plasma carnitine concentration was low (2.5 nmol/L, normal 17.6-54.0 nmoIIL). The diagnosis of MCAD deficiency was confirmed by enzymatic studies in fibroblasts. The subject's older brother was tested and was found not to have biochemical evidence of MCAD deficiency.
In family B the subject (the second boy in the family) was 9 months old when he was first admitted to a hospital with an encephalopathy, metabolic acidosis, and hyperuricemia after a febrile illness. He recovered completely and was discharged without a specific diagnosis. At age 3 years he was admitted again with a Reye-like disease of hepatic encephalopathy. He had metabolic acidosis and hyperuricemia.
His urine contained increased concentrations of dicarboxylic acids, hexanoylglycine, and phenylpropionylglycine. High concentrations of octanoylcarnitine were found in his urine and low cannitine concentrations were documented in his plasma and muscle. His asymptomatic 4-year-old brother was found to have very high concentrations of urinary hexanoylglycine and phenylpropionylglycine. A newborn brother was also tested and was found to be biochemically normal. Enzymatic studies with [9,10(n)-3H]myristate confirmed MCAD deficiencies in the two boys with abnormal organic aciduria.
Results
The two above-described families were tested for the 985 A-to-G mutant allele by both the ARMS method and the method involving Nco I restriction enzyme digest of PCR product. Five normal control subjects were also tested for the presence of A-to-G mutant allele by the ARMS method. approach successfully used by other investigators (7) (8) (9) . As shown in our results, the primers thus designed are specific in amplifring the wild-type and mutant alleles at the 985 nucleotide position. Although primers lacking the deliberately introduced mismatch in the nucleotide next to the 3'-terminal end might also work under certain conditions, we did not investigate the allele-specificity of such primers here. Currently, the most commonly used method involves PCR amplification followed by a restriction enzyme (Nco I) digestion (1, 2). In our hands, the ARMS method is both less laborious and more reproducible than the PCR/Nco I digestion method. This is particularly true in the detection of heterozygote carriers, in which the ARMS method results in amplification product in each of the two reactions with use of different primers. The PCR'Nco I digestion, however, may be more prone to error of interpretation, depending on whether the restriction enzyme digest is carried out under optimal conditions. In conclusion, we used ARMS to successfully detect the MCAD 985 mutant alleles in two families. The method is simple and reproducible. Because of the high prevalence of MCAD deficiency and the difficulty of laboratory diagnosis by conventional methods, ARMS for the detection of the MCAD 985 mutant allele should be useful in all routine clinical laboratories involved with the diagnosis of inborn errors of metabolism.
ARMS has now been used for diagnosing many disorders (7) (8) (9) . The successful application of the ARMS Although the finding of these compounds in urine organic acid analysis should raise the index of suspicion for MCAD deficiency, dicarboxylic aciduria may be present in many other conditions. More specificdiagnosis depends on the finding of glycine conjugates, such as hexanoylglycine, suberylglycine, and phenyipropionylglycine. However, these compoundsare often present in small quantities and may easily be overlooked. Definitive diagnosis requires either enzyme analysis, which is cumbersome, or analysis of medium-chain fatty acid acylcarnitines, which requires instrumentation (such as the tandem mass spectrometer) that is not widely available (12) . The PCR-based method for mutation analysis is relatively simple. It is particularly useful as a diagnostic tool when a disease is causedprimarily by one or a few alleles. Thus, MCAD deficiency lends itself to this method because the 985 A-to-G transition accounts for -89% of all mutant alleles. In fact, of the 55 patients reported in a recent study, 44 were homozygousand 10 were heterozygous for this mutation, sothat 98% of the affected patients carried at least one copy of this allele (4) .
The subject in family A is homozygous for the 985 A-to-G mutation. In family B, the two affected siblings are heterozygous for the 985 A-to-G allele but manifest clinical and biochemical findings of MCAD deficiency. From these results, the most likely explanation is that the mother in family B carries a mutation not involving the A-to-G transition and the affected children are compound heterozygotes with one 985 A-to-G allele and one rarer mutant allele.
We used ARMS for detecting the MCAD 985 A-to-G allele. ARMS was originally reported as a means to detect mutations in the a1-antitrypsin gene (9) and was recently used to detect several disorders and to determine apolipoprotein E alleles (7, 8) . The technique is based on the observation that primers used in PCR, xi74 t,x174 I Al A2 A3 A4 I 81 I,
